Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ANVS Annovis Bio, Inc. | ABBV AbbVie |
|---|---|---|
| Price | $1.14 +3.6% | $263.96 -0.0% |
| StockIQ Score | 35F Weak Risk: High | 59C Moderate Risk: High |
| Technical | 6F | 85A |
| Fundamental | 42D | 57C |
| Growth | 52C- | 34F |
| Fair Value | 50C- | 33F |
| News | 50C- | 100A+ |
| Quality | — | 42D |
| Risk | 34F | 36F |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
ABBV has a higher overall investorScore (53 vs 37) and better technical (58 vs 10) and fundamental scores (56 vs 42) than ANVS. In contrast, ANVS leads in growth (52 vs 34) and valuation (50 vs 33). The rating reflects this, with ABBV rated MODERATE and ANVS rated WEAK.